We are live on ! Find out more
MD icon

Pediatrix Medical

332 hedge funds and large institutions have $5.6B invested in Pediatrix Medical in 2014 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 119 increasing their positions, 127 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 33

0.39% less ownership

Funds ownership: 100.15%99.76% (-0.39%)

1% less funds holding

Funds holding: 334332 (-2)

3% less capital invested

Capital invested by funds: $5.78B → $5.6B (-$181M)

6% less repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 127

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

83% less call options, than puts

Call options by funds: $2.02M | Put options by funds: $11.8M

Holders
332
Holders Change
-2
Holders Change %
-0.6%
% of All Funds
9.63%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.12%
New
35
Increased
119
Reduced
127
Closed
33
Calls
$2.02M
Puts
$11.8M
Net Calls
-$9.83M
Net Calls Change
-$9.71M
Name Holding Trade Value Shares
Change
Change in
Stake
LOAMS
151
Lombard Odier Asset Management (Switzerland)
Switzerland
$2.92M +$3.01M +53,006 New
TRSOTSOK
152
Teachers Retirement System of the State of Kentucky
Kentucky
$2.9M
Macquarie Group
153
Macquarie Group
Australia
$2.79M
CWG
154
C WorldWide Group
Denmark
$2.74M +$2.84M +50,000 New
BPIM
155
Brant Point Investment Management
New York
$2.71M -$3.47M -61,100 -55%
SOMRS
156
State of Michigan Retirement System
Michigan
$2.61M +$45.4K +800 +2%
RHJA
157
Rice Hall James & Associates
California
$2.61M -$556K -9,804 -17%
CNB
158
City National Bank
California
$2.6M -$139K -2,453 -5%
WG
159
Winton Group
United Kingdom
$2.52M +$195K +3,439 +8%
ARC
160
Absolute Return Capital
Massachusetts
$2.44M -$3.52M -61,964 -58%
RPAM
161
Rhenman & Partners Asset Management
Sweden
$2.41M +$794K +14,000 +47%
Invesco
162
Invesco
Georgia
$2.39M -$46.3M -815,618 -95%
HighTower Advisors
163
HighTower Advisors
Illinois
$2.35M +$157K +2,776 +7%
IGIM
164
I.G. Investment Management
Manitoba, Canada
$2.33M +$180K +3,174 +8%
BUB
165
BBVA USA Bancshares
Texas
$2.32M +$557K +9,826 +30%
SDIC
166
South Dakota Investment Council
South Dakota
$2.29M +$2.37M +41,800 New
BG
167
BlackRock Group
United Kingdom
$2.16M -$54.5K -960 -2%
N
168
Nuveen
North Carolina
$2.13M
SFU
169
Stonehage Fleming (UK)
United Kingdom
$1.92M -$329K -5,800 -14%
Nisa Investment Advisors
170
Nisa Investment Advisors
Missouri
$1.88M -$431K -7,600 -18%
Jacobs Levy Equity Management
171
Jacobs Levy Equity Management
New Jersey
$1.86M +$1.93M +34,000 New
CCMG
172
Clark Capital Management Group
Pennsylvania
$1.84M +$134K +2,365 +8%
RFC
173
Regions Financial Corp
Alabama
$1.79M -$450K -7,923 -20%
B
174
Baird
Wisconsin
$1.7M +$21.8K +385 +1%
LCP
175
LGT Capital Partners
Switzerland
$1.65M +$1.7M +30,000 New

MD Hedge Fund Activity: Q3 2014 in Review

332 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2014, worth a combined $5.6B — down 3.1% from $5.78B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MD positions and 33 closed out — a net gain of 2 holders — while 119 added to existing stakes and 127 trimmed.

The largest buyer was William Blair & Company, adding an estimated $67.1M. The largest seller was Fidelity Investments, cutting an estimated $105M.

  • 332 institutional investors held Pediatrix Medical (MD) as of Q3 2014, down from 334 in Q2 2014.
  • Funds reported $5.6B of Pediatrix Medical stock for Q3 2014, down 3.1% quarter-over-quarter.
  • 35 funds opened new Pediatrix Medical positions in Q3 2014 and 33 closed out, a net change of +2 holders.
  • The largest Pediatrix Medical buyer in Q3 2014 was William Blair & Company, an estimated $67.1M added.
  • The largest Pediatrix Medical seller in Q3 2014 was Fidelity Investments, an estimated $105M sold.

Based on aggregated 13F filings for Q3 2014.